Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
about
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataEarly versus delayed erythropoietin for the anaemia of end-stage kidney diseaseErythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysisEarly versus delayed erythropoietin for the anaemia of end-stage kidney diseaseDarbepoetin for the anaemia of chronic kidney diseaseAntioxidants for chronic kidney diseaseInterventions for erythropoietin-resistant anaemia in dialysis patientsSafety of off-label erythropoiesis-stimulating agents for critically ill patientsErythropoiesis stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysisParenteral versus oral iron therapy for adults and children with chronic kidney diseaseDarbepoetin for the anaemia of chronic kidney diseaseParenteral versus oral iron therapy for adults and children with chronic kidney diseaseVitamin D compounds for people with chronic kidney disease not requiring dialysisAntioxidants for chronic kidney diseaseAnemia of chronic disease: a harmful disorder or an adaptive, beneficial response?Guidelines for the management of chronic kidney diseasePharmacologic management of chronic reno-cardiac syndromeCinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trialsHemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysisThe effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction.Optimal and continuous anaemia control in a cohort of dialysis patients in SwitzerlandEffect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsHFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit.Patient satisfaction with in-centre haemodialysis care: an international surveyEffects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.Assessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting.Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocolImprovements in renal replacement therapy practice patterns in estoniaAnemia in the preoperative patient.Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes.Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus StudyThe optimum hematocrit.Monitoring of hemodialysis quality-of-care indicators: why is it important?An update on the controversies in anemia management in chronic kidney disease: lessons learned and lost.Hepatitis C treatment completion rates in routine clinical care.Protective effect of erythropoietin against myocardial injury in rats with sepsis and its underlying mechanisms.The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.
P2860
Q21261840-74E48A42-05B2-4BDA-A924-AABFE65E461CQ24187089-10F51032-0A69-4379-AA22-DAE4901D33CBQ24187413-EDC81B40-0F42-4904-898B-6244604B000DQ24194838-85CBB4AF-33A9-4766-8D75-DF692FFF80C3Q24197780-6C4DD73B-008C-43C4-9BBC-CE50805FF1D9Q24198197-C228E6DB-F0F7-4C42-84C0-D73189CEB59DQ24200248-25AAC819-685D-4E69-B219-57577B7A2064Q24200811-00060ABA-D972-44D7-96EF-41645FB45418Q24201673-BE78D86F-CE52-4E36-A040-9343725D0F88Q24203895-69E1F7F9-587C-407B-AC50-694130D1D113Q24234732-C51A15DD-5162-48A0-8F55-6E9D739DB881Q24240303-C9E0C12A-8BF1-4614-AFCB-17906554A3E6Q24240439-10ECA90F-C2D3-4E4F-A212-2E7EE1A20DB7Q24241102-66225DF5-AE67-4C93-9D32-14428D458822Q24651385-4A7EB7CD-F6DE-4C17-A467-10FF446B0007Q24657844-4A80BE06-C639-4B20-9112-5CD6162F9E23Q26829812-8A0B7868-B2CF-4997-84C2-EB56B485E2E8Q26851487-4F928E73-0E4C-489B-A0A6-61CB50949B9CQ27023213-6DD9D15D-6602-49F4-8BF9-F8AD3EBECE31Q30475623-557603F3-2902-4564-AA1B-58E240D5A1B4Q33392426-65528708-E218-44C4-9D36-69BDBEB0821DQ33413288-2334A51F-15B7-443F-8337-2F27B1634AE3Q33471093-ABF5669B-5FE1-44A6-B14D-AD31A7EAD1A8Q33512133-2737F5DF-0D9C-49FA-805B-2381C9FD311BQ33691308-67E98537-4670-4DFC-9FBA-91F1158ECDB9Q33726150-570915D9-F71F-45BE-A510-6846D80E9DC5Q33757650-945DEA54-E45A-48D8-B96A-44CBF8306A43Q33881779-59F7450F-3FEA-4EFE-9763-EA6D7C2A39A3Q33992079-3F4D4505-A8E1-41A7-BD3B-1723DD8BED7BQ34036570-F472CFC1-3577-4417-925C-1756B166A223Q34052950-9F6E26B9-D66A-41CB-B30B-7FC9FD29D159Q34258204-42052BE0-5A99-4A86-97B5-0107B90D5780Q34372505-852B6E22-910F-469D-A90F-0D980B47C923Q34403856-546FA69D-DE77-4203-BA76-F48508001661Q34679370-6A3B1924-CC80-4A1E-BF60-2A7F647B8761Q34738880-A25981A3-DBC1-4506-A98D-CD25450B36A7Q34896347-6029C7A3-6156-4727-BBE0-5DDEC73765B5Q35093134-2C1E9EA1-52EC-4833-9483-54AC5906952FQ35201722-F0A906A0-8C04-4224-82EF-C2B531A271C0Q35249642-46A48683-E44E-49B2-877A-14868A98E4B0
P2860
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mortality and target haemoglob ...... ythropoietin: a meta-analysis.
@en
type
label
Mortality and target haemoglob ...... ythropoietin: a meta-analysis.
@en
prefLabel
Mortality and target haemoglob ...... ythropoietin: a meta-analysis.
@en
P2093
P1433
P1476
Mortality and target haemoglob ...... ythropoietin: a meta-analysis.
@en
P2093
Arintaya Phrommintikul
Maros Elsik
Steven Joseph Haas
P304
P356
10.1016/S0140-6736(07)60194-9
P407
P50
P577
2007-02-01T00:00:00Z